- Lobbying
- Lobbying by Novo Nordisk, Inc.
Lobbying Relationship
Bills mentioned
H.R.1577: Treat and Reduce Obesity Act of 2021
Sponsor: Ron Kind (D-Wis.)
H.R.1577: Building United States Infrastructure through Limited Delays and...
Sponsor: Garret Graves (R-La.)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Shawna Francis Watley | LA, Sen. J. Robert Kerrey |
Ashley Lawrence | Intern, Rep. Charles Rangel; Leg. Correspondent, Rep. Gregory Meeks |
Jim Davis | Member, U.S. House of Representatives |
Micah Burbanks-Ivey | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
U.S. House of Representatives
Health Issues
U.S. House of Representatives
Health Issues
U.S. House of Representatives
Health Issues
U.S. House of Representatives
Health Issues
U.S. House of Representatives
Health Issues
U.S. House of Representatives
Health Issues
U.S. House of Representatives
Health Issues
U.S. House of Representatives
Health Issues
U.S. House of Representatives
Health Issues
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate